國立虎尾科技大學 |

The Leber Congenital Amaurosis CEP290 Cat Model : = Working Towards a Cure.

Record Type:	Language materials, manuscript : Monograph/item
Title/Author:	The Leber Congenital Amaurosis CEP290 Cat Model :/
Reminder of title:	Working Towards a Cure.
Author:	Minella, Andrea Louise.
Description:	1 online resource (216 pages)
Notes:	Source: Dissertation Abstracts International, Volume: 78-10(E), Section: B.
Contained By:	Dissertation Abstracts International78-10B(E).
Subject:	Medicine. -
Online resource:	click for full text (PQDT)
ISBN:	9781369762525

The Leber Congenital Amaurosis CEP290 Cat Model : = Working Towards a Cure.
Minella, Andrea Louise.

The Leber Congenital Amaurosis CEP290 Cat Model :Working Towards a Cure. - 1 online resource (216 pages)

Source: Dissertation Abstracts International, Volume: 78-10(E), Section: B.

Thesis (Ph.D.)

Includes bibliographical references

Leber Congenital Amaurosis (LCA) is an early-onset and severe inherited retinal dystrophy. The most commonly implicated gene is the centrosomal 290kDa (CEP290) gene. There are currently no treatments for LCA CEP290. Animal models are integral for treatment safety and efficacy testing, with a feline model for CEP290 retinopathies showing promise for this purpose. This model has a spontaneous mutation in CEP290 resulting in a progressive retinal degeneration and vision loss. This mutation alters splicing and is predicted to result in a truncated protein. CEP290 is integrally involved in the transport within photoreceptor cells, localizing to the interconnecting cilium.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2018

Mode of access: World Wide Web

ISBN: 9781369762525Subjects--Topical Terms:

644133
Medicine.
Index Terms--Genre/Form:

554714
Electronic books.

The Leber Congenital Amaurosis CEP290 Cat Model : = Working Towards a Cure.
LDR:04866ntm a2200421Ki 4500 001 909143
005 20180419121557.5
006 m o u
007 cr mn||||a|a||
008 190606s2017 xx obm 000 0 eng d
020 $a 9781369762525
035 $a (MiAaPQ)AAI10280955
035 $a (MiAaPQ)grad.msu:15329
035 $a AAI10280955
040 $a MiAaPQ $b eng $c MiAaPQ
099 $a TUL $f hyy $c available through World Wide Web
100 1 $a Minella, Andrea Louise. $3 1179734
245 1 4 $a The Leber Congenital Amaurosis CEP290 Cat Model : $b Working Towards a Cure.
264 0 $c 2017
300 $a 1 online resource (216 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertation Abstracts International, Volume: 78-10(E), Section: B.
500 $a Adviser: Simon M. Petersen-Jones.
502 $a Thesis (Ph.D.) $c Michigan State University $d 2017.
504 $a Includes bibliographical references
520 $a Leber Congenital Amaurosis (LCA) is an early-onset and severe inherited retinal dystrophy. The most commonly implicated gene is the centrosomal 290kDa (CEP290) gene. There are currently no treatments for LCA CEP290. Animal models are integral for treatment safety and efficacy testing, with a feline model for CEP290 retinopathies showing promise for this purpose. This model has a spontaneous mutation in CEP290 resulting in a progressive retinal degeneration and vision loss. This mutation alters splicing and is predicted to result in a truncated protein. CEP290 is integrally involved in the transport within photoreceptor cells, localizing to the interconnecting cilium.
520 $a The CEP290 mutant cat ("rdAc") has a milder phenotype than the phenotype most commonly associated with CEP290 mutations in people. Understanding the reason for this milder phenotype was an important aim of this dissertation. We analyzed the wild-type and truncated mutant transcript levels and total CEP290 protein levels in cat retinal tissue across genotypes (wild-type, heterozygous, homozygous mutant). Our findings show that the milder phenotype in mutant cats is likely the result of low-level production of wild-type transcript and protein combined with production of truncated protein that we suspect retains some function. These measures can also serve as objective markers of disease progression or treatment success in future studies.
520 $a Further objective markers were investigated utilizing spectral-domain optical coherence tomography. By analyzing photoreceptor layer thickness (receptor plus/REC +) and the ellipsoid zone (EZ), a zone noted to change with disease in people, we showed that REC+ thickness and EZ integrity can be used as markers of disease progression. These findings support the cat as a CEP290 model, and show the affected cats have a degeneration with central retinal sparing as described in human patients.
520 $a We also developed an in vitro tool by developing primary fibroblast cell cultures from skin samples of CEP290 cats. We showed that cilia formation, which involves CEP290, can be induced, opening the door for future cilia studies. We assessed cilia length as an objective marker of disease, however, no difference was found in cilia length across genotypes. Utilizing this new tool, we tested a CRISPR/Cas-9 genome editing treatment in an attempt to replace the mutated region with a sequence that would direct splicing to the correct location. We achieved high efficiency transduction of CRISPR components, however, we failed to detect insertion of our chosen sequence.
520 $a As we work towards a treatment, it is imperative to develop an optimized method to deliver the treatment to feline photoreceptors. To achieve this aim we tested hybrid adeno-associated viral (AAV) vectors, the retinal viral vector of choice, in the wild-type feline retina. We showed that all serotypes studied, AAV2/2, 2/5, 2/8, and 2/9, transduce photoreceptor cells with AAV2/8 and 2/9 showing higher transduction and faster onset. Interestingly, we found more efficient transduction of cones than rods, an unusual finding that speaks to the need to use caution when extrapolating across species.
520 $a It is our hope that these data will help the scientific community move closer to treatments for CEP290 retinopathies. We have added to the understanding of the rdAc cat model and determined objective markers, supported the cat as a model, and have made progress towards a treatment.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2018
538 $a Mode of access: World Wide Web
650 4 $a Medicine. $3 644133
650 4 $a Molecular biology. $3 583443
650 4 $a Veterinary science. $3 1179701
655 7 $a Electronic books. $2 local $3 554714
690 $a 0564
690 $a 0307
690 $a 0778
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a Michigan State University. $b Comparative Medicine and Integrative Biology. $3 1179735
773 0 $t Dissertation Abstracts International $g 78-10B(E).
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10280955 $z click for full text (PQDT)